Position in NTRA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$239,147
New position
Shares Held
881
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#641
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 50%
Shared 0%
None 50%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $3,302,947 across 6 Diagnostics & Research names. NTRA ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,495 | $1,752,253 | |
| 2 | DHR |
Danaher Corp /De/
|
2,749 | $523,629 | |
| 3 | A |
Agilent Technologies, Inc.
|
2,236 | $297,007 | |
| 4 | ILMN |
Illumina, Inc.
|
1,539 | $270,602 | |
| 5 | NTRA |
Natera, Inc.
This page
|
881 | $239,147 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
416 | $220,309 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,147 | 881 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||